No Picture
Boston Cambridge Biotech Trending News

Groundbreaking Data-Sharing Initiative Launches to Increase Understanding of Antimicrobial Resistance

Leading pharmaceutical companies join Vivli’s new global register to accelerate research into antibiotic resistant bacteria CAMBRIDGE, Mass., June 21, 2022 /PRNewswire/ — The Antimicrobial Resistance Register, unveiled today by the nonprofit organization Vivli, makes it […]

No Picture
Boston Cambridge Biotech Trending News

QurAlis Announces the Appointment of Anne C. Whitaker as Chair of the Board

Industry veteran brings proven track record in building successful businesses and leading high-performance teams across large pharmaceutical, biotech, and specialty pharma companies CAMBRIDGE, Mass., June 21, 2022 /PRNewswire/ — QurAlis Corporation, a biotech company developing… […]

No Picture
Boston Cambridge Biotech Trending News

SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting

WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today presented Tolerizing Antigen Carrier (TACs) nonclinical results at the 2022 Federation of Clinical Immunology […]

No Picture
Boston Cambridge Biotech Trending News

PerkinElmer and Novartis Collaborate to Address the Unmet Need of Sickle Cell Disease in Sub-Saharan Africa

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced that it is collaborating with Novartis, a leading global medicines company, to expand newborn screening for sickle cell disease […]

No Picture
Boston Cambridge Biotech Trending News

Marengo Therapeutics Expands Executive Leadership Team with Svetlana Makhni Joining as Chief Financial Officer

CAMBRIDGE, Mass., June 15, 2022 /PRNewswire/ — Marengo Therapeutics, Inc., a company pioneering novel therapeutics that directly target the Vβ chain of the T cell receptor (TCR) to activate the right T cell subsets to […]